Systemic mastocytosis - PubMed (original) (raw)
Review
Systemic mastocytosis
Cem Akin et al. Annu Rev Med. 2004.
Abstract
Systemic mastocytosis is a clonal disorder of the mast cell and its progenitor. The symptoms of systemic mastocytosis are due to the pathologic accumulation and activation of mast cells in various tissues such as bone marrow, skin, gastrointestinal tract, liver, and spleen. Recent studies revealed striking differences between the molecular and cellular biology of mast cells in patients with mastocytosis and those of healthy individuals. These findings are being used in formulating diagnostic criteria as well as designing novel treatment approaches to the disease.
Similar articles
- Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
Proelss J, Wenzel J, Ko Y, Bieber T, Bauer R. Proelss J, et al. J Am Acad Dermatol. 2007 Mar;56(3):453-7. doi: 10.1016/j.jaad.2006.09.020. Epub 2006 Oct 30. J Am Acad Dermatol. 2007. PMID: 17317486 - [Mastocytosis in childhood].
Renke J, Lange M. Renke J, et al. Przegl Lek. 2006;63(7):551-3. Przegl Lek. 2006. PMID: 17203807 Review. Polish. - Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.
Alvarez-Twose I, González de Olano D, Sánchez-Muñoz L, Matito A, Esteban-López MI, Vega A, Mateo MB, Alonso Díaz de Durana MD, de la Hoz B, Del Pozo Gil MD, Caballero T, Rosado A, Sánchez Matas I, Teodósio C, Jara-Acevedo M, Mollejo M, García-Montero A, Orfao A, Escribano L. Alvarez-Twose I, et al. J Allergy Clin Immunol. 2010 Jun;125(6):1269-1278.e2. doi: 10.1016/j.jaci.2010.02.019. J Allergy Clin Immunol. 2010. PMID: 20434205 - [Systemic mastocytosis. A review of current diagnostic and therapeutic approaches].
Pari F, Zamagni MD, Carnevali C, Pagani M, Rabbi C, Cantore M, Cavazzini G, Aitini E, Smerieri F. Pari F, et al. Recenti Prog Med. 1999 Mar;90(3):169-72. Recenti Prog Med. 1999. PMID: 10228358 Review. Italian. - Case report: pathologic long bone fracture in a patient with systemic mastocytosis.
King JJ, Crawford EA, Iwenofu OH, Fox EJ. King JJ, et al. Clin Orthop Relat Res. 2007 Jun;459:263-9. doi: 10.1097/BLO.0b013e3180487ced. Clin Orthop Relat Res. 2007. PMID: 17327804
Cited by
- Evaluation of the relationship between mast cell activation and postural orthostatic tachycardia syndrome in children and adolescents.
Bayrak YE, Kayabey O, Basar EZ, Simsek IE, Aydogan M, Babaoglu A. Bayrak YE, et al. North Clin Istanb. 2024 Aug 2;11(4):315-321. doi: 10.14744/nci.2023.64920. eCollection 2024. North Clin Istanb. 2024. PMID: 39165715 Free PMC article. - Unraveling the Rare Entity of KIT D816V-Negative Systemic Mastocytosis.
Alyamany R, Albachir CA, Alsaleh S, Hamad A, Abdulwali SK, Alotaibi AS, Ahmed SO, Alfayez M. Alyamany R, et al. J Hematol. 2024 Jun;13(3):128-136. doi: 10.14740/jh1279. Epub 2024 Jun 28. J Hematol. 2024. PMID: 38993735 Free PMC article. - Skin and bones: systemic mastocytosis and bone.
Wang M, Seibel MJ. Wang M, et al. Endocrinol Diabetes Metab Case Rep. 2023 May 11;2023(2):22-0408. doi: 10.1530/EDM-22-0408. Print 2023 May 1. Endocrinol Diabetes Metab Case Rep. 2023. PMID: 37166908 Free PMC article. - Antineoplastic efficacy profiles of avapritinib and nintedanib in KIT D816V+ systemic mastocytosis: a preclinical study.
Degenfeld-Schonburg L, Gamperl S, Stefanzl G, Schruef AK, Sadovnik I, Bauer K, Smiljkovic D, Eisenwort G, Peter B, Greiner G, Hadzijusufovic E, Schwaab J, Sperr WR, Hoermann G, Kopanja S, Szépfalusi Z, Hoetzenecker K, Jaksch P, Reiter A, Arock M, Valent P. Degenfeld-Schonburg L, et al. Am J Cancer Res. 2023 Feb 15;13(2):355-378. eCollection 2023. Am J Cancer Res. 2023. PMID: 36895976 Free PMC article. - Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis.
Reiter A, Schwaab J, DeAngelo DJ, Gotlib J, Deininger MW, Pettit KM, Alvarez-Twose I, Vannucchi AM, Panse J, Platzbecker U, Hermine O, Dybedal I, Lin HM, Rylova SN, Ehlert K, Dimitrijević S, Radia DH. Reiter A, et al. Blood Adv. 2022 Nov 8;6(21):5750-5762. doi: 10.1182/bloodadvances.2022007539. Blood Adv. 2022. PMID: 35640224 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources